After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Sonnet BioTherapeutics Holdings Inc. (SONN) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0001, or -0.04%, to $0.2499. The Sonnet BioTherapeutics Holdings Inc. has recorded 33,466 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 at the 2023 American Association for Cancer Research (AACR) Annual Meeting.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Stocks Info
Sonnet BioTherapeutics Holdings Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $0.25 and fluctuated between $0.2590 as its day high and $0.2220 as its day low. The current market capitalization of Sonnet BioTherapeutics Holdings Inc. is $5.12M. A total of 1.6 million shares were traded on the day, compared to an average of 1.05M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, SONN has seen 1 BUY and 2 SELL insider trades, representing the acquisition of 60,000 and the disposition of 2,457 shares. Over the last 12 months, there were 15 BUYs and 6 SELLs from insiders. Insiders purchased 337,189 shares during that period but sold 123,823.
In the most recent transaction, Mohan Pankaj bought 60,000 shares of SONN for 0.58 per share on Mar 15. After the transaction, the Chairman, President and CEO now owns 181,731 company shares.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for SONN in the last 3 months, the mean price target is $11.85 with high estimates of $17.00 and low estimates of $6.70. In terms of 52-week highs and lows, SONN has a high of $4.56 and a low of $0.22.
As of this writing, SONN has an earnings estimate of $-0.49 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of $-0.43 per share and a lower estimate of $-0.56. The company reported an EPS of $-1.67 in the last quarter, which was -10.60% lower than expectations of $-1.51.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SONN’s latest balance sheet shows that the firm has $27.62M in Cash & Short Term Investments as of fiscal 2021. There were $125.88k in debt and $6.70M in liabilities at the time. Its Book Value Per Share was $-0.51, while its Total Shareholder’s Equity was $22.26M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 2 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SONN is Buy with a score of 5.00. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.
